report_lead_image_with_gradient.png
Q3 2026

Sweden Market Snapshot

Download this Report
To download this report, please complete the form below

PitchBook clients can access this report and its Excel data pack via the Research Center on the PitchBook Platform.

Exits and fundraising stall in Swedish private markets, putting LP liquidity in focus

Sweden’s venture market got smaller but pricier in Q3. VC deal value fell sharply QoQ, with a handful of mega-rounds making up the bulk of the total. Healthcare took the largest share of value, led by Neko Health’s Series C, which lifted its valuation to several times its previous level. AI app builder Lovable also raised a large round at a record valuation for the company, helping push aggregate unicorn value sharply higher YTD. On the PE side, deal value dropped while deal count fell to its lowest level in three years, leaving 2026 on course to fall well short of last year’s total.

Exits and fundraising are the real pressure points. VC exit value was subdued, while PE exit value fell significantly QoQ. The Ellos Group listing was the only IPO of the quarter, and its shares slipped below the offer price within days. Fundraising has all but stalled for both VC and PE funds, far below recent annual averages. All eyes are on the close of EQT’s flagship Fund XI.


Table of contents
Commentary: Exits and fundraising stall in Sweden 3
City comparison 4
Private markets 5
       Sweden top LPs 6
       Sweden top investors 7
VC deal activity 8
VC exit activity 10
VC fundraising activity 11
PE deal activity 12
PE exit activity 14
PE fundraising activity 15
Corporate acquisition activity 16